Infinium Pharmachem (NSE:INFINIUM) Beneish M-Score: -2.44 (As of Jul. 03, 2026)


NSE:INFINIUM Infinium Pharmachem Ltd NSE:INFINIUM
86 GF Score
Price ₹204.30
GF Value ₹303.68
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is Infinium Pharmachem Beneish M-Score?

Infinium Pharmachem NSE:INFINIUM +2.15% 86 Beneish M-Score is -2.44 as of Jul. 03, 2026. GuruFocus rates NSE:INFINIUM with a GF Score™ of 86/100 and a GF Value™ of ₹303.68 (Significantly Undervalued). The stock has 2 warning signs investors should review. Among 1,527 Chemicals companies, Infinium Pharmachem ranks worse than 55.66% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.44 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Infinium Pharmachem's Beneish M-Score or its related term are showing as below:

NSE:INFINIUM' s Beneish M-Score Range Over the Past 10 Years
Min: -2.62   Med: -1.99   Max: 7.49
Current: -2.44

During the past 7 years, the highest Beneish M-Score of Infinium Pharmachem was 7.49. The lowest was -2.62. And the median was -1.99.


Infinium Pharmachem Beneish M-Score Historical Data

* Premium members only.

The historical data trend for Infinium Pharmachem's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Infinium Pharmachem Beneish M-Score Chart

Infinium Pharmachem Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Beneish M-Score
Get a 7-Day Free Trial -2.62 -1.99 -1.51 7.49 -2.44

Infinium Pharmachem Semi-Annual Data
Mar20 Mar21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only -1.51 0.00 7.49 0.00 -2.44

NSE:INFINIUM vs DOW: Beneish M-Score Comparison

For the Chemicals subindustry, Infinium Pharmachem's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Infinium Pharmachem Beneish M-Score vs Chemicals Industry

For the Chemicals industry and Basic Materials sector, Infinium Pharmachem's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Infinium Pharmachem's Beneish M-Score falls into.


NSE:INFINIUM
86GF Score
Infinium Pharmachem Ltd NSE:INFINIUM
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Infinium Pharmachem Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Infinium Pharmachem for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.9037+0.528 * 1.1295+0.404 * 1.1513+0.892 * 1.2179+0.115 * 1.3153
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0+4.679 * -0.123382-0.327 * 0.4701
=-2.44

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar26) TTM:Last Year (Mar25) TTM:
Total Receivables was ₹383 Mil.
Revenue was ₹1,896 Mil.
Gross Profit was ₹411 Mil.
Total Current Assets was ₹1,100 Mil.
Total Assets was ₹1,749 Mil.
Property, Plant and Equipment(Net PPE) was ₹282 Mil.
Depreciation, Depletion and Amortization(DDA) was ₹31 Mil.
Selling, General, & Admin. Expense(SGA) was ₹0 Mil.
Total Current Liabilities was ₹287 Mil.
Long-Term Debt & Capital Lease Obligation was ₹0 Mil.
Net Income was ₹122 Mil.
Gross Profit was ₹0 Mil.
Cash Flow from Operations was ₹337 Mil.
Total Receivables was ₹348 Mil.
Revenue was ₹1,557 Mil.
Gross Profit was ₹381 Mil.
Total Current Assets was ₹1,399 Mil.
Total Assets was ₹1,984 Mil.
Property, Plant and Equipment(Net PPE) was ₹223 Mil.
Depreciation, Depletion and Amortization(DDA) was ₹33 Mil.
Selling, General, & Admin. Expense(SGA) was ₹46 Mil.
Total Current Liabilities was ₹636 Mil.
Long-Term Debt & Capital Lease Obligation was ₹56 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(382.992 / 1896.317) / (348.002 / 1557.092)
=0.201966 / 0.223495
=0.9037

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(381.056 / 1557.092) / (410.854 / 1896.317)
=0.244723 / 0.216659
=1.1295

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (1099.983 + 282.335) / 1749.36) / (1 - (1399.169 + 223.145) / 1983.855)
=0.209815 / 0.182242
=1.1513

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=1896.317 / 1557.092
=1.2179

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(32.945 / (32.945 + 223.145)) / (30.609 / (30.609 + 282.335))
=0.128646 / 0.09781
=1.3153

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(0 / 1896.317) / (45.526 / 1557.092)
=0 / 0.029238
=0

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((0 + 286.737) / 1749.36) / ((55.744 + 635.913) / 1983.855)
=0.16391 / 0.348643
=0.4701

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(121.502 - 0 - 337.342) / 1749.36
=-0.123382

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Infinium Pharmachem has a M-score of -2.44 suggests that the company is unlikely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of -2.44 mean?
Infinium Pharmachem (NSE:INFINIUM) has a Beneish M-Score of -2.44 as of Jul. 03, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Infinium Pharmachem and its competitors. According to the industry distribution chart, Infinium Pharmachem ranks #850 out of 1527 companies in the Chemicals industry, placing it in the top 55.7%.
Is Infinium Pharmachem's Beneish M-Score too high?
Infinium Pharmachem's current Beneish M-Score is -2.44. Based on the distribution chart, Infinium Pharmachem ranks #850 out of 1527 companies in the Chemicals industry, which is below the industry midpoint. Overall, Infinium Pharmachem has a GF Score™ of 86/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Infinium Pharmachem's Beneish M-Score compare to DOW?
According to the Chemicals industry distribution chart, Infinium Pharmachem ranks #850 out of 1527 companies for Beneish M-Score. This places Infinium Pharmachem in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Chemicals company?
A good Beneish M-Score depends on the Chemicals industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Infinium Pharmachem and its competitors. Infinium Pharmachem's current Beneish M-Score is -2.44. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Infinium Pharmachem stock overvalued right now?
Based on GuruFocus' analysis, Infinium Pharmachem (NSE:INFINIUM) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹303.68, compared to a current price of ₹204.30 — trading 32.7% below its estimated fair value. The current Beneish M-Score is -2.44. Infinium Pharmachem's overall GF Score™ is 86/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For Infinium Pharmachem (NSE:INFINIUM), the current Beneish M-Score is -2.44 as of Jul. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Infinium Pharmachem (NSE:INFINIUM) Overvalued in 2026?

Based on GuruFocus' analysis, Infinium Pharmachem stock appears to be undervalued. The current stock price of ₹204.30 is trading 32.7% below its estimated GF Value™ of ₹303.68. GuruFocus considers Infinium Pharmachem to be Significantly Undervalued.

Key valuation signals for NSE:INFINIUM:

  • Beneish M-Score: -2.44
  • GF Value™: ₹303.68 vs. price of ₹204.30 (32.7% below fair value)
  • GF Score™: 86/100 with 2 warning signs

No single metric tells the full story. See the NSE:INFINIUM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Infinium Pharmachem Business Description

Address V.U. Nagar GIDC Road, Near Sardar Patel Statue, Suite 205, Sigma Prime, 2nd Floor, District Anand, Vallabh Vidhyanagar, GJ, IND, 388120
Infinium Pharmachem Ltd is engaged in the business of manufacturing and supplying Iodine, Iodine Derivatives and Active Pharmaceutical Ingredients (APIs). It provides fully integrated customized services from R & D to Commercial scale manufacturing and packaging for its products to the Pharmaceutical, Agrochemical, Nutraceutical, Speciality Chemicals and various other chemicals Industries.
86GF Score

Get the complete analysis for NSE:INFINIUM

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹204.30
Price
₹303.68
GF Value